How to select the appropriate "neoadjuvant therapy" for hepatocellular carcinoma

Expert Opin Pharmacother. 2018 Aug;19(11):1167-1170. doi: 10.1080/14656566.2018.1498843. Epub 2018 Jul 16.

Authors

Ken Liu^{1

2

3}, Geoffrey W McCaughan^{1

2

3}

Affiliations

¹ a AW Morrow Gastroenterology and Liver Centre , Royal Prince Alfred Hospital , Sydney , NSW , Australia.
² b Liver Injury and Cancer Program , The Centenary Institute , Sydney , NSW , Australia.
³ c Sydney Medical School , The University of Sydney , Sydney , NSW , Australia.

PMID: 30011239
DOI: 10.1080/14656566.2018.1498843

No abstract available

Keywords: Bridging; downstaging; hepatocellular carcinoma; liver transplantation; locoregional therapy; neoadjuvant therapy.

Publication types

Editorial